<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2012</study_start_year><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2122943</full_dataset_link><location>China</location><study_start_month>6</study_start_month><keyword>Irinotecan</keyword><keyword>Adjuvant chemotherapy</keyword><keyword>Oxaliplatin</keyword><keyword>Advanced colorectal cancer</keyword><keyword>FOLFOX</keyword><keyword>FOLFIRI</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer</name><description>the aim of this study is to observe the effect of irinotecan-based regimen in patients with advanced colorectal cancer.</description><dates><creation>2012-06-15</creation></dates><accession>2122943</accession><cross_references><ClinicalTrials___gov>NCT01566942</ClinicalTrials___gov></cross_references></HashMap>